Kolexia
Cumin Isabelle Oncologie médicale
Cumin Isabelle
Oncologie médicale
Hôpital du Scorff
Lorient, France
36 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Tumeurs du poumon Tumeurs du pancréas Carcinomes Métastase tumorale Carcinome épithélial de l'ovaire Néphrocarcinome

Collaborateurs

Voir plus
Lamy Regine
Lamy Regine
Hôpital du Scorff, Lorient, France
Chéneau Caroline
Chéneau Caroline
Sgsm Onco, Cesson-Sévigné, France
Brouard Anne
Brouard Anne
Hôpital du Scorff, Lorient, France
Egreteau Joelle
Egreteau Joelle
Hôpital du Scorff, Lorient, France

Industries

Voir plus
MSD
4 collaboration(s)
Dernière en 2022
GSK
4 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023
Ipsen
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
CHRONO - Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
Essai Clinique (ARCAGY/ GINECO GROUP)   22 décembre 2023
Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post-EMA-approval descriptive study with a geriatric oncology focus.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology   14 octobre 2021
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
International journal of cancer   01 août 2019
P-136 Evolution of efficacy and safety of cetuximab with the determination of RAS status in Metastatic Colorectal Cancer (mCRC) elderly patients
ESMO 18th World Congress on Gastrointestinal Cancer, 29 June-2 July 2016, Barcelona, Spain   01 juin 2016
Third- and fourth-line treatment in patients with RCC: Results of a prospective multicentric non-randomised study (IVOIRE study).
2016 ASCO Annual Meeting I   20 mai 2016
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas ( ).
Oncologie (Paris, France)   21 décembre 2014
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
American journal of hematology   27 août 2014
FOLFIRINOX in first-line metastatic pancreatic cancer regimen (FLMPC): What profile of patients take a real advantage? Real world cohort from cancer observatory from Brittany and Pays de la Loire areas.
2014 ASCO Annual Meeting I   20 mai 2014
Efficacy and safety of FOLFIRINOX in patients with metastatic pancreatic cancer.
2014 Gastrointestinal Cancers Symposium   20 janvier 2014
Efficacy and safety of FOLFIRINOX in patients with pancreatic metastatic cancer.
2013 Gastrointestinal Cancers Symposium   01 février 2013